A detailed history of Flagship Harbor Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Flagship Harbor Advisors, LLC holds 34,157 shares of BMY stock, worth $1.82 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
34,157
Previous 29,477 15.88%
Holding current value
$1.82 Million
Previous $1.51 Million 22.49%
% of portfolio
0.12%
Previous 0.11%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024

BUY
$47.98 - $54.4 $224,546 - $254,592
4,680 Added 15.88%
34,157 $1.85 Million
Q4 2023

Jan 10, 2024

BUY
$48.48 - $57.85 $29,475 - $35,172
608 Added 2.11%
29,477 $1.51 Million
Q3 2023

Oct 17, 2023

SELL
$57.89 - $64.73 $89,787 - $100,396
-1,551 Reduced 5.1%
28,869 $1.68 Million
Q2 2023

Jul 11, 2023

SELL
$63.71 - $70.74 $128,566 - $142,753
-2,018 Reduced 6.22%
30,420 $1.95 Million
Q1 2023

Apr 12, 2023

BUY
$65.71 - $74.53 $6,111 - $6,931
93 Added 0.29%
32,438 $2.25 Million
Q4 2022

Jan 13, 2023

BUY
$68.48 - $81.09 $22,940 - $27,165
335 Added 1.05%
32,345 $0
Q3 2022

Oct 13, 2022

BUY
$0.13 - $76.84 $210 - $124,250
1,617 Added 5.32%
32,010 $2.28 Million
Q2 2022

Jul 13, 2022

BUY
$72.62 - $79.98 $60,347 - $66,463
831 Added 2.81%
30,393 $2.34 Million
Q1 2022

Apr 13, 2022

BUY
$61.48 - $73.72 $91,974 - $110,285
1,496 Added 5.33%
29,562 $2.16 Million
Q4 2021

Feb 10, 2022

BUY
$53.63 - $62.52 $257,531 - $300,221
4,802 Added 20.64%
28,066 $1.75 Million
Q2 2021

Jul 26, 2021

BUY
$61.91 - $67.42 $44,141 - $48,070
713 Added 3.16%
23,264 $1.56 Million
Q1 2021

May 03, 2021

SELL
$59.34 - $66.74 $68,062 - $76,550
-1,147 Reduced 4.84%
22,551 $1.42 Million
Q4 2020

Feb 08, 2021

BUY
$57.74 - $65.43 $142,329 - $161,284
2,465 Added 11.61%
23,698 $1.47 Million
Q3 2020

Oct 13, 2020

BUY
$57.43 - $63.64 $9,648 - $10,691
168 Added 0.8%
21,233 $1.28 Million
Q2 2020

Jul 31, 2020

BUY
$54.82 - $64.09 $127,127 - $148,624
2,319 Added 12.37%
21,065 $1.24 Million
Q1 2020

May 12, 2020

SELL
$46.4 - $67.43 $44,497 - $64,665
-959 Reduced 4.87%
18,746 $1.05 Million
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $140,248 - $182,941
2,850 Added 16.91%
19,705 $1.27 Million
Q3 2019

Oct 22, 2019

SELL
$42.77 - $50.71 $311,921 - $369,828
-7,293 Reduced 30.2%
16,855 $854,000
Q2 2019

Jul 22, 2019

BUY
$44.62 - $49.34 $528,702 - $584,629
11,849 Added 96.34%
24,148 $1.1 Million
Q1 2019

Apr 15, 2019

BUY
$45.12 - $53.8 $66,687 - $79,516
1,478 Added 13.66%
12,299 $586,000
Q4 2018

Jan 28, 2019

SELL
$48.76 - $63.23 $45,639 - $59,183
-936 Reduced 7.96%
10,821 $562,000
Q3 2018

Nov 05, 2018

BUY
$55.19 - $62.25 $12,196 - $13,757
221 Added 1.92%
11,757 $730,000
Q2 2018

Aug 14, 2018

BUY
$50.53 - $62.98 $9,348 - $11,651
185 Added 1.63%
11,536 $638,000
Q1 2018

Apr 24, 2018

SELL
$59.92 - $68.98 $157,529 - $181,348
-2,629 Reduced 18.81%
11,351 $696,000
Q4 2017

Jan 24, 2018

SELL
$59.94 - $65.35 $4,855 - $5,293
-81 Reduced 0.58%
13,980 $856,000
Q3 2017

Oct 23, 2017

BUY
$55.23 - $63.74 $60,697 - $70,050
1,099 Added 8.48%
14,061 $897,000
Q2 2017

Aug 09, 2017

BUY
N/A
12,962
12,962 $732,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Flagship Harbor Advisors, LLC Portfolio

Follow Flagship Harbor Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Flagship Harbor Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Flagship Harbor Advisors, LLC with notifications on news.